Chittaranjan Andrade, MD

Dr Andrade is Adjunct Professor, Department of Psychiatry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India, and Senior Professor (Retd), Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, India

JCP
Clinical and Practical Psychopharmacology

November 23, 2021

Dr Andrade considers the limitations of the odds ratio in a study of prolactin-raising vs prolactin-sparing antipsychotics and breast cancer risk, with the aim of helping readers understand how...
JCP
Clinical and Practical Psychopharmacology

October 12, 2021

This article discusses a recent large cohort study of neurodevelopmental outcomes (ADHD, autism) after gestational exposure of antipsychotics—including the limitations of the study.
JCP
Clinical and Practical Psychopharmacology

October 5, 2021

This article looks at recent large studies of the safety of SGAs in order to weigh the benefits and risks of treatment during pregnancy.
JCP
Letter to the Editor

September 21, 2021

Dr Andrade responds to criticism of his recent article on prazosin for alcohol use disorder.
JCP
Letter to the Editor

August 24, 2021

Dr Andrade replies to a letter commenting on his recent article on the efficacy of ECT.
JCP
Clinical and Practical Psychopharmacology

August 10, 2021

What contributes to relapse after electroconvulsive therapy? Dr Andrade discusses the findings of 2 recent studies on this question and critically examines their methodology.
JCP
Clinical and Practical Psychopharmacology

August 3, 2021

Dr Andrade takes a closer look at the use of sevoflurane for anesthesia during electroconvulsive therapy; although its routine use is not advisable, it may be a good solution...
JCP
Clinical and Practical Psychopharmacology

June 8, 2021

Dr Andrade discusses the findings of a meta-analysis and two recent RCTs that indicate fluoxetine may not be a good choice in patients recovering from stroke.
JCP
Clinical and Practical Psychopharmacology

June 1, 2021

β-Blocker treatment has long been associated with depression, but is there more to the story than meets the eye? Dr Andrade considers the findings of a recent large meta-analysis—and...
JCP
Clinical and Practical Psychopharmacology

March 30, 2021

Electroconvulsive therapy has a negative connotation in many circles, but is it getting a bad rap? Dr Andrade offers thoughtful counterpoints to the criticism.
JCP
Clinical and Practical Psychopharmacology

March 23, 2021

Could prazosin help patients with alcohol use disorder who experience intense withdrawal symptoms? Dr Andrade considers the evidence and the findings of a recent large RCT.
JCP
Clinical and Practical Psychopharmacology

February 18, 2021

Two recent meta-analyses found little effect of N-acetylcysteine augmentation in MDD or bipolar depression, although some past research has indicated its efficacy. In this article, Dr Andrade takes a...

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe